Recomendation_2017_30_10_2017_HR

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

217.Pietersen A. H., Hellemann H. (1991) Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. DanishNorwegianFlecainideMulticenterStudyGroup.AmJCardiol67:713– 717.

218.Ruder M. A., Davis J. C., Eldar M., et al. (1986) Clinical and electrophysiologiccharacterizationofautomaticjunctionaltachycardia inadults.Circulation73:930–937.

219.KumagaiK.,YamatoH.,YamanouchiY.,etal.(1990)Automaticjunctional tachycardiainanadult.ClinCardiol13:813–816.

220.Cook J. R.,Steinberg J. S.(1991)Anincessantformofjunctionalectopic tachycardia in an adult responsive to a class 1C agent. Am Heart J 122:1487–1489.

221.Kuck K. H., Kunze K. P., Schlüter M., et al. (1988) Encainide versus flecainideforchronicatrialandjunctionalectopictachycardia.AmJ Cardiol62:37L 44L.

222.HamdanM.,VanHare G. F.,FisherW.,etal.(1996)Selectivecatheter ablation of the tachycardia focus in patients with nonreentrant junctionaltachycardia.AmJCardiol78:1292–1297.

223.Law I. H.,VonBergen N. H.,Gingerich J. C.,etal.(2006)Transcatheter cryothermalablationofjunctionalectopictachycardiainthenormal heart.HeartRhythm3:903–907.

224.Padanilam B. J., Manfredi J. A., Steinberg L. A., et al. (2008) Differentiatingjunctionaltachycardiaandatrioventricularnodereentrytachycardiabasedonresponsetoatrialextrastimuluspacing. JAmCollCardiol52:1711–1717.

225.Mamchur S. E., Kurilin M. Y. (2012) High-amplitude pace mapping increases safety of radiofrequency catheter ablation of parahisian ectopicfoci.PacingClinElectrophysiol35:1458–1463.

226.Scheinman M. M.,Gonzalez R. P.,Cooper M. W.,etal.(1994)Clinicaland electrophysiologicfeaturesandroleofcatheterablationtechniquesin adultpatientswithautomaticatrioventricularjunctionaltachycardia. AmJCardiol74:565–572.

227.Fan R., Tardos J. G., Almasry I., et al. (2011) Novel use of atrial overdrivepacingtorapidlydifferentiatejunctionaltachycardiafrom atrioventricularnodalreentranttachycardia.HeartRhythm8:840–844.

228.Srivathsan K., Gami A. S., Barrett R., et al. (2008) Differentiating atrioventricularnodalreentranttachycardiafromjunctionaltachycardia: novelapplicationofthedeltaH-Ainterval.JCardiovascElectrophysiol 19:1–6.

431

ГЛАВА3

229.Anand R. G., Rosenthal G. L., Van Hare G. F., et al. (2009) Is the mechanismofsupraventriculartachycardiainpediatricsinfluenced byage,genderorethnicity?CongenitHeartDis4:464–468.

230.Garson A. Jr.., Gillette P. C. (1981) Electrophysiologic studies of supraventriculartachycardiainchildren.I. Clinical-electrophysiologic correlations.AmHeartJ102:233–250.

231.Ko J. K., Deal B. J., Strasburger J. F., et al. (1992) Supraventricular tachycardiamechanismsandtheiragedistributioninpediatricpatients. AmJCardiol69:1028–1032.

232.Weindling S. N.,Saul J. P.,Walsh E. P.(1996)Efficacyandrisksofmedical therapyforsupraventriculartachycardiainneonatesandinfants.Am HeartJ131:66–72.

233.Cain N., Irving C., Webber S., et al. (2013) Natural history of Wolff- Parkinson-White syndrome diagnosed in childhood. Am J Cardiol 112:961–965.

234.TimmermansC.,Smeets J. L.,Rodriguez L. M.,etal.(1995)Aborted suddendeathintheWolff-Parkinson-Whitesyndrome.AmJCardiol 76:492–494.

235.Bromberg B. I.,Lindsay B. D.,Cain M. E.,etal.(1996)Impactofclinical historyandelectrophysiologiccharacterizationofaccessorypathways onmanagementstrategiestoreducesuddendeathamongchildren withWolff-Parkinson-Whitesyndrome.JAmCollCardiol27:690–695.

236.Di Mambro C., Russo M. S., Righi D., et al. (2015) Ventricular preexcitation:symptomaticandasymptomaticchildrenhavethesame potentialriskofsuddencardiacdeath.Europace,617–621.

237.PediatricandCongenitalElectrophysiologySociety(PACES),Heart RhythmSociety(HRS),AmericanCollegeofCardiologyFoundation (ACCF), et al. (2012) PACES/HRS expert consensus statement on themanagementoftheasymptomaticyoungpatientwithaWolff- Parkinson-White(WPW,ventricularpreexcitation)electrocardiographic pattern.DevelopedinpartnershipbetweenthePediatricandCongenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS).HeartRhythm9:1006–1024..

238.Dixon J., Foster K., Wyllie J., et al. (2005) Guidelines and adenosine dosinginsupraventriculartachycardia.ArchDisChild90:1190–1191

239.Díaz-ParraS.,Sánchez-YañezP.,Zabala-Argüelles I.,etal.(2014)Use of adenosine in the treatment of supraventricular tachycardia in a pediatricemergencydepartment.PediatrEmergCare30:388–393.

432

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

240.Losek J. D.,EndomE.,DietrichA.,etal.(1999)Adenosineandpediatric supraventriculartachycardiaintheemergencydepartment:multicenter studyandreview.AnnEmergMed33:185–191.

241.Sanatani S., Potts J. E., Reed J. H., et al. (2012) The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomizedcontrolledtrialcomparingtheefficacyandsafetyofdigoxin versuspropranololforprophylaxisofsupraventriculartachycardiain infants.CircArrhythmElectrophysiol5:984–991.

242.PfammatterJP,PaulT. Idiopathicventriculartachycardiaininfancyand childhood:amulticenterstudyonclinicalprofileandoutcome.Working GrouponDysrhythmiasandElectrophysiologyoftheAssociationfor EuropeanPediatricCardiology.JAmCollCardiol1999;33:2067–2072.

243.Wang S, Zhu W, Hamilton RM, Kirsh JA, Stephenson EA, Gross GJ. Diagnosis-specificcharacteristicsofventriculartachycardiainchildren withstructurallynormalhearts.HeartRhythm2010;7:1725–1731.

244.Collins KK, Schaffer MS, Liberman L, Saarel E, Knecht M, Tanel RE, Bradley D, Dubin AM, Paul T, Salerno J, Bar-Cohen Y, Sreeram N, SanataniS,LawIH,BlaufoxA,BatraA,MoltedoJM,vanHareGF,ReedJ, RoPS,KuglerJ,AndersonC,TriedmanJK.Fascicularandnonfascicular leftventriculartachycardiasintheyoung:aninternationalmulticenter study.JCardiovascElectrophysiol2013;24:640–648.

245.Schneider HE, Kriebel T, Jung K, Gravenhorst VD, Paul T. Catheter ablation of idiopathic left and right ventricular tachycardias in the pediatric population using noncontact mapping. Heart Rhythm 2010;7:731–739.

246.BlaufoxAD,FelixGL,SaulJP.Radiofrequencycatheterablationininfants ≤18monthsold:whenisitdoneandhowdotheyfare?:short-termdata fromthepediatricablationregistry.Circulation2001;104:2803–2808.

247.LapageMJ,BradleyDJ,DickM2nd.Verapamilininfants:anexaggerated fear?PediatrCardiol2013;34:1532–1534.

248.Deal B. J., Keane J. F., Gillette P. C., et al. (1985) Wolff-Parkinson- White syndrome and supraventricular tachycardia during infancy: managementandfollow-up.JAmCollCardiol5:130–135.

249.VillainE.,BonnetD.,AcarP.,etal.(1998)[Recommendationsforthe treatmentofrecurrentsupraventriculartachycardiaininfants].Arch Pediatr5:133–138.

250.Fish F. A.,Gillette P. C.,Benson D. W. Jr..(1991)Proarrhythmia,cardiac arrestanddeathinyoungpatientsreceivingencainideandflecainide. ThePediatricElectrophysiologyGroup.JAmCollCardiol18:356–365.

433

ГЛАВА3

251.Lee P. — ​C., Hwang B., Chen S. — ​A., et al. (2007) The results of radiofrequencycatheterablationofsupraventriculartachycardiain children.PacingClinElectrophysiol30:655–661.

252.Van Hare G. F., Javitz H., Carmelli D., et al. (2004) Prospective assessmentafterpediatriccardiacablation:demographics,medical profiles,andinitialoutcomes.JCardiovascElectrophysiol15:759–770.

253.AiyagariR.,Saarel E. V.,Etheridge S. P.,etal.(2005)Radiofrequency ablationforsupraventriculartachycardiainchildren<or=15kgissafe andeffective.PediatrCardiol26:622–626.

254.Schaffer M. S.,Gow R. M.,Moak J. P.,etal.(2000)Mortalityfollowing radiofrequencycatheterablation(fromthePediatricRadiofrequency Ablation Registry). Participating members of the Pediatric ElectrophysiologySociety.AmJCardiol86:639–643.

255.Van Hare G. F., Javitz H., Carmelli D., et al. (2004) Prospective assessment after pediatric cardiac ablation: recurrence at 1 year after initially successful ablation of supraventricular tachycardia. HeartRhythm1:188–196.

256.Buddhe S., Singh H., Du W., et al. (2012) Radiofrequency and cryoablationtherapiesforsupraventriculararrhythmiasintheyoung: five-yearreviewofefficacies.PacingClinElectrophysiol35:711–717.

257.ChiuS. —N​.,Lu C. —W​.,ChangC. —W​.,etal.(2009)Radiofrequency catheterablationofsupraventriculartachycardiaininfantsandtoddlers. CircJ73:1717–1721

258.Collins K. K.,VanHare G. F.,Kertesz N. J.,etal.(2009)Pediatricnonpostoperativejunctionalectopictachycardiamedicalmanagementand interventionaltherapies.JAmCollCardiol53:690–697.

259.Batra A. S.,Chun D. S.,Johnson T. R.,etal.(2006)Aprospectiveanalysis oftheincidenceandriskfactorsassociatedwithjunctionalectopic tachycardia following surgery for congenital heart disease. Pediatr Cardiol27:51–55

260.Andreasen J. B., Johnsen S. P., Ravn H. B. (2008) Junctional ectopic tachycardia after surgery for congenital heart disease in children. IntensiveCareMed34:895–902.

261.Haas N. A.,Camphausen C. K.(2008)Impactofearlyandstandardized treatment with amiodarone on therapeutic success and outcome in pediatric patientswithpostoperativetachyarrhythmia. JThorac CardiovascSurg136:1215–1222.

434

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

262.Laird W. P.,Snyder C. S.,Kertesz N. J.,etal.(2003)Useofintravenous amiodaroneforpostoperativejunctionalectopictachycardiainchildren. PediatrCardiol24:133–137.

263.KovacikovaL.,HakacovaN.,DobosD.,etal.(2009)Amiodaroneasa first-line therapy for postoperative junctional ectopic tachycardia. AnnThoracSurg88:616–622.

264.Walsh E. P.,Saul J. P.,Sholler G. F.,etal.(1997)Evaluationofastaged treatmentprotocolforrapidautomaticjunctionaltachycardiaafter operationforcongenitalheartdisease.JAmCollCardiol29:1046–1053.

265.vanEngelen A. D.,WeijtensO.,Brenner J. I.,etal.(1994)Management outcomeandfollow-upoffetaltachycardia.JAmCollCardiol24:1371– 1375.

266.Jaeggi E. T., Carvalho J. S.,DeGrootE.,et al.(2011)Comparisonof transplacentaltreatmentoffetalsupraventriculartachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenterstudy.Circulation124:1747–1754.

267.vanderHeijden L. B.,Oudijk M. A.,Manten G. T.R.,etal.(2013)Sotalol asfirst-linetreatmentforfetaltachycardiaandneonatalfollow-up. UltrasoundObstetGynecol42:285–293.

268.Strasburger J. F.,Cuneo B. F.,Michon M. M.,etal.(2004)Amiodarone therapyfordrug-refractoryfetaltachycardia.Circulation109:375–379.

269.Bouchardy J., Therrien J., Pilote L., et al. (2009) Atrial arrhythmias inadultswithcongenitalheartdisease.Circulation120:1679–1686.

270.Bernier M., Marelli A. J., Pilote L., et al. (2010) Atrial arrhythmias in adultpatientswithright-versusleft-sidedcongenitalheartdisease anomalies.AmJCardiol106:547–551.

271.EngelfrietP.,BoersmaE.,OechslinE.,etal.(2005)Thespectrumof adultcongenitalheartdiseaseinEurope:morbidityandmortalityin a5yearfollow-upperiod.TheEuroHeartSurveyonAdultCongenital HeartDisease.EurHeartJ26:2325–2333.

272.Trojnarska O., Grajek S., Kramer L., et al. (2009) Risk factors of supraventriculararrhythmiainadultswithcongenitalheartdisease. CardiolJ16:218–226.

273.Verheugt C. L., Uiterwaal C. S.P.M., van der Velde E. T., et al. (2008) Genderand outcomeinadult congenital heartdisease.Circulation 118:26–32.

274.Collins K. K., Love B. A., Walsh E. P., et al. (2000) Location of acutely successfulradiofrequencycatheterablationofintraatrialreentrant

435

ГЛАВА3

tachycardia inpatientswithcongenitalheartdisease.Am JCardiol 86:969–974.

275.deGroot N. M.S.,ZeppenfeldK.,Wijffels M. C.,etal.(2006)Ablationof focalatrialarrhythmiainpatientswithcongenitalheartdefectsafter surgery:roleofcircumscribedareaswithheterogeneousconduction. HeartRhythm3:526–535.

276.KoyakZ.,KroonB.,deGroot J. R.,etal.(2013)Efficacyofantiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias.AmJCardiol112:1461–1467.

277.Mah D. Y.,Alexander M. E.,CecchinF.,etal.(2011)Theelectroanatomic mechanismsofatrialtachycardiainpatientswithtetralogyofFallot anddoubleoutletrightventricle.JCardiovascElectrophysiol22:1013– 1017.

278.WasmerK.,KöbeJ.,Dechering D. G.,etal.(2013)Isthmus-dependent right atrial flutter as the leading cause of atrial tachycardias after surgicalatrialseptaldefectrepair.IntJCardiol168:2447–2452.

279.Cuypers J. A.A.E.,OpićP.,Menting M. E.,et al.(2013)Theunnatural historyofanatrialseptaldefect:longitudinal35yearfollowupafter surgicalclosureatyoungage.Heart99:1346–1352.

280.KhairyP.,AboulhosnJ.,Gurvitz M. Z.,etal.(2010)Arrhythmiaburdenin adultswithsurgicallyrepairedtetralogyofFallot:amulti-institutional study.Circulation122:868–875.

281.de Groot N. M.S., Atary J. Z., Blom N. A., et al. (2010) Long-term outcomeafterablativetherapyofpostoperativeatrialtachyarrhythmia inpatientswithcongenitalheartdiseaseandcharacteristicsofatrial tachyarrhythmiarecurrences.CircArrhythmElectrophysiol3:148–154.

282.Hårdhammar P. A.,vanBeusekom H. M.,Emanuelsson H. U.,etal.(1996) Reductioninthromboticeventswithheparin-coatedPalmaz-Schatz stentsinnormalporcinecoronaryarteries.Circulation93:423–430.

283.Tanner H., Lukac P., Schwick N., et al. (2004) Irrigated-tip catheter ablationofintraatrialreentranttachycardiainpatientslateaftersurgery ofcongenitalheartdisease.HeartRhythm1:268–275.

284.Triedman J. K.,Saul J. P.,Weindling S. N.,etal.(1995)Radiofrequency ablationofintra-atrialreentranttachycardiaaftersurgicalpalliation ofcongenitalheartdisease.Circulation91:707–714.

285.DeMazumderD.,Lake D. E.,ChengA.,etal.(2013)Dynamicanalysis of cardiac rhythms for discriminating atrial fibrillation from lethal ventriculararrhythmias.CircArrhythmElectrophysiol6:555–561.

436

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

286.YapS. —C​.,HarrisL.,Silversides C. K.,etal.(2010)Outcomeofintra- atrialre-entranttachycardiacatheterablationinadultswithcongenital heartdisease:negativeimpactof ageandcomplexatrialsurgery.J AmCollCardiol56:1589–1596.

287.ScaglioneM.,CaponiD.,EbrilleE.,etal.(2014)Verylong-termresultsof electroanatomic-guidedradiofrequencyablationofatrialarrhythmias in patients with surgically corrected atrial septal defect. Europace, 1800–1807.

288.Hart R. G., Pearce L. A., Aguilar M. I. (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvularatrialfibrillation.AnnInternMed146:857–867.

289.Field J. M., Hazinski M. F., Sayre M. R., et al. (2010) Part 1: executive summary: 2010 American Heart Association guidelines for cardiopulmonaryresuscitationandemergencycardiovascularcare. Circulation122:S640–S656.

290.Gallagher M. M.,Hennessy B. J.,EdvardssonN.,etal.(2002)Embolic complicationsof directcurrentcardioversionofatrialarrhythmias: association with low intensity of anticoagulation at the time of cardioversion.JAmCollCardiol40:926–933.

291.SchmidtH.,vonderReckeG.,IllienS.,etal.(2001)Prevalenceofleft atrialchamberandappendagethrombiinpatientswithatrialflutter anditsclinicalsignificance.JAmCollCardiol38:778–784.

292.Lanzarotti C. J.,OlshanskyB.(1997)Thromboembolisminchronicatrial flutter:istheriskunderestimated?JAmCollCardiol30:1506–1511.

293.Feltes T. F.,Friedman R. A.(1994)Transesophagealechocardiographic detection of atrial thrombi in patients with nonfibrillation atrial tachyarrhythmias and congenital heart disease. J Am Coll Cardiol 24:1365–1370.

294.JanuaryC.T.,Wann L. S.,Alpert J. S.,etal.(2014)2014AHA/ACC/HRS guidelineforthemanagementofpatientswithatrialfibrillation:areport oftheAmericanCollegeofCardiology/AmericanHeartAssociation Task Force on Practice Guidelines and the Heart Rhythm Society. J AmCollCardiol64:e1–e76.

295.Ammash N. M., Phillips S. D., Hodge D. O., et al. (2012) Outcome of direct current cardioversion for atrial arrhythmias in adults with congenitalheartdisease.IntJCardiol154:270–274.

296.Khairy P., Van Hare G. F., Balaji S., et al. (2014) PACES/HRS expert consensus statement on the recognition and management of arrhythmiasinadultcongenitalheartdisease.Developedinpartnership

437

ГЛАВА3

between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Heart Rhythm 11: e102–e165.

297.diMarco J.P., Sellers T. D., Lerman B. B., et al. (1985) Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.JAmCollCardiol6:417–425.

298.Haines D. E., DiMarco J.P. (1990) Sustained intraatrial reentrant tachycardia: clinical, electrocardiographic and electrophysiologic characteristicsandlong-termfollow-up.JAmCollCardiol15:1345– 1354.

299.Kall J. G., Kopp D., Olshansky B., et al. (1995) Adenosine-sensitive atrialtachycardia.PacingClinElectrophysiol18:300–306.

300.OlshanskyB.,OkumuraK.,Hess P. G.,etal.(1988)Useofprocainamide with rapid atrial pacing for successful conversion of atrial flutter to sinusrhythm.JAmCollCardiol11:359–364.

301.Heisel A., Jung J., Stopp M., et al. (1997) Facilitating influence of procainamide on conversion of atrial flutter by rapid atrial pacing. EurHeartJ18:866–869.

302.Hoyer A. W., Balaji S. (2007) The safety and efficacy of ibutilide in children and in patients with congenital heart disease. Pacing Clin Electrophysiol30:1003–1008.

303.Crawford W., Plumb V. J., Epstein A. E., et al. (1989) Prospective evaluation of transesophageal pacing for the interruption of atrial flutter.AmJMed86:663–667.

304.Rhodes L. A.,Walsh E. P.,Saul J. P.(1995)Conversionofatrialflutterin pediatricpatientsbytransesophagealatrialpacing:asafe,effective, minimallyinvasiveprocedure.AmHeartJ130:323–327.

305.BrockmeierK., Ulmer H. E.,Hessling G.(2002) Terminationofatrial reentrant tachycardias by using transesophageal atrial pacing. J Electrocardiol35(Suppl):159–163.

306.Stephenson E. A.,CasavantD.,TuziJ.,etal.(2003)Efficacyofatrial antitachycardia pacing using the Medtronic AT500 pacemaker in patientswithcongenitalheartdisease.AmJCardiol92:871–876.

307.Rao S. O., Boramanand N. K., Burton D. A., et al. (2009) Atrial tachycardiasinyoungadultsandadolescentswithcongenitalheart disease: conversion using single dose oral sotalol. Int J Cardiol 136:253–257.

438

КЛИНИЧЕСКИЕРЕКОМЕНДАЦИИПОПРОВЕДЕНИЮ ЭЛЕКТРОФИЗИОЛОГИЧЕСКИХПРОЦЕДУР УПАЦИЕНТОВСНАРУШЕНИЯМИРИТМАСЕРДЦА

308.Wells R., Khairy P., Harris L., et al. (2009) Dofetilide for atrial arrhythmiasincongenitalheartdisease:amulticenterstudy.Pacing ClinElectrophysiol32:1313–1318.

309.Murphy J. G., Gersh B. J., McGoon M.D., et al. (1990) Long-term outcomeaftersurgicalrepairofisolatedatrialseptaldefect.Follow- upat27to32years.NEnglJMed323:1645–1650.

310.KonstantinidesS.,GeibelA.,OlschewskiM.,etal.(1995)Acomparison ofsurgicalandmedicaltherapyforatrialseptaldefectinadults.NEngl JMed333:469–473.

311.Pfammatter J. P., Paul T., Ziemer G., et al. (1995) Successful managementofjunctionaltachycardiabyhypothermiaaftercardiac operationsininfants.AnnThoracSurg60:556–560.

312.GiambertiA.,ChessaM.,ForestiS.,etal.(2006)Combinedatrialseptal defectsurgicalclosureandirrigatedradiofrequencyablationinadult patients.AnnThoracSurg82:1327–1331.

313.Reich J. D.,AuldD.,HulseE.,etal.(1998)ThePediatricRadiofrequency Ablation Registry’s experience with Ebstein’s anomaly. Pediatric ElectrophysiologySociety.JCardiovascElectrophysiol9:1370–1377

314.CappatoR.,SchlüterM.,WeissC.,etal.(1996)Radiofrequencycurrent catheterablationofaccessoryatrioventricularpathwaysinEbstein’s anomaly.Circulation94:376–383.

315.Khositseth A., Danielson G.  K., Dearani J. A., et al. (2004) SupraventriculartachyarrhythmiasinEbsteinanomaly:management andoutcome.JThoracCardiovascSurg128:826–833.

316.BockeriaL.,GolukhovaE.,DadashevaM.,etal.(2005)Advantagesand disadvantagesofone-stageandtwo-stagesurgeryforarrhythmias andEbstein’sanomaly.EurJCardiothoracSurg28:536–540.

317.Khairy P., Harris L., Landzberg M. J., et al. (2008) Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles:amulticenterstudy.CircArrhythmElectrophysiol1:250–257.

318.Banchs J. E.,Baquero G. A.,Nickolaus M. J.,etal.(2014)Clinicalefficacy ofdofetilideforthetreatmentofatrialtachyarrhythmiasinadultswith congenitalheartdisease.CongenitHeartDis9:221–227.

319.Tanel R. E., Walsh E. P., Lulu J. A., et al. (1995) Sotalol for refractory arrhythmiasinpediatricandyoungadultpatients:initialefficacyand long-termoutcome.AmHeartJ130:791–797.

320.LukacP.,Pedersen A. K.,Mortensen P. T.,etal.(2005)Ablationofatrial tachycardiaaftersurgeryforcongenitalandacquiredheartdisease

439

ГЛАВА3

usinganelectroanatomicmappingsystem:whichcircuitstoexpect inwhichsubstrate?HeartRhythm2:64–72.

321.YapS. —C​.,HarrisL.,DownarE.,etal.(2012)Evolvingelectroanatomic substrate and intra-atrial reentrant tachycardia late after Fontan surgery.JCardiovascElectrophysiol23:339–345.

322.Jones D. G., Jarman J. W.E., Lyne J. C., et al. (2013) The safety and efficacy of trans-baffle puncture to enable catheter ablation of atrialtachycardiasfollowingtheMustardprocedure:asinglecentre experienceandliteraturereview.IntJCardiol168:1115–1120.

323.Kalman J. M.,VanHareG.F.,Olgin J. E.,etal.(1996)Ablationof‘incisional’ reentrantatrialtachycardiacomplicatingsurgeryforcongenitalheart disease.Useofentrainmenttodefineacriticalisthmusofconduction. Circulation93:502–512.

324.UedaA.,Suman-Horduna I.,MantziariL.,etal.(2013)Contemporary outcomesofsupraventriculartachycardiaablationincongenitalheart disease: a single-centerexperience in 116 patients. Circ Arrhythm Electrophysiol6:606–613.

325.deGroot N. M.S.,LukacP.,Blom N. A.,etal.(2009)Long-termoutcome ofablativetherapyofpostoperativesupraventriculartachycardiasin patientswithuniventricularheart:aEuropeanmulticenterstudy.Circ ArrhythmElectrophysiol2:242–248.

326.Silversides C. K., Salehian O., Oechslin E., et al. (2010) Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: complex congenitalcardiaclesions.CanJCardiol26:e98–e117.

327.Warnes C. A., Williams R. G., Bashore T. M., et al. (2008) ACC/AHA 2008guidelinesforthemanagementofadultswithcongenitalheart disease:areportoftheAmericanCollegeofCardiology/AmericanHeart AssociationTaskForceonPracticeGuidelines(WritingCommitteeto DevelopGuidelinesontheManagement ofAdultsWithCongenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International SocietyforAdultCongenitalHeartDisease,SocietyforCardiovascular AngiographyandInterventions,andSocietyofThoracicSurgeons.J AmCollCardiol52:e143–e263.

328.Thorne S. A.,Barnes I.,CullinanP.,etal.(1999)Amiodarone-associated thyroiddysfunction:riskfactorsinadultswithcongenitalheartdisease. Circulation100:149–154.

440